Sara Abalde-Cela

Staff Researcher
Medical Devices

Dr Sara Abalde-Cela is a Staff Researcher at the International Iberian Nanotechnology Laboratory (INL) in Braga, Portugal (2019-now). She works at the Department of Life Sciences, within the Medical Devices group. The research project she is involved in focuses on the development of microfluidic platforms for the detection of cancer cells, as a continuation of her Marie Curie project (2017-2019). The goal of her project is to develop a real-time and on-chip method for circulating tumour cell detection based on Surface enhanced-Raman scattering (SERS) spectroscopy.

Sara holds a PhD in nanotechnology by the Universidade de Vigo (Spain, 2008-2013) and postdoctoral experience at the University of Cambridge (UK, 2013-2016). Her experience in research gathers expertise from nanotechnology and Raman spectroscopy to microfluidics and microdroplets for biotechnology applications. Sara won several funding, research awards and recognitions along with her career, she has around 30 contributions to conferences, 17 peer-reviewed publications and 1 filed patent. She has also been involved in lecturing, science outreach and startup programs in Cambridge, London, Vigo and Braga. Sara is also the co-founder and CTO of the start-up RUBYnanomed (2018 – now).

Selected Publications